Back to today’s briefing

Story perspectives

Study Reveals CDKN2A Gene May Protect Against Esophageal Cancer

1/7/2025

43 9

Summary

Story summary

New research uncovers a surprising twist: mutations in the CDKN2A gene, once thought to solely contribute to esophageal cancer, may actually offer protection against its early stages. Individuals with Barrett’s esophagus carrying these mutations, but lacking p53 mutations, showed a reduced risk of developing cancer, prompting a reevaluation of cancer mutation roles and risk assessment strategies.

1 of 1

Story summary

New research uncovers a surprising twist: mutations in the CDKN2A gene, once thought to solely contribute to esophageal cancer, may actually offer protection against its early stages. Individuals with Barrett’s esophagus carrying these mutations, but lacking p53 mutations, showed a reduced risk of developing cancer, prompting a reevaluation of cancer mutation roles and risk assessment strategies.